# SLC9A1

## Overview
The SLC9A1 gene encodes the Na+/H+ exchanger isoform 1 (NHE1), a critical transmembrane protein that plays a vital role in maintaining intracellular pH and cell volume by exchanging intracellular protons for extracellular sodium ions. This protein is ubiquitously expressed across mammalian cells and is involved in various physiological processes, including cell growth, proliferation, differentiation, and apoptosis. NHE1's structure is characterized by multiple transmembrane alpha-helices, forming a homodimer essential for its function in the plasma membrane. The protein's activity is modulated by interactions with several regulatory proteins, such as calcineurin B-homologous protein 1 (CHP1) and calmodulin, which influence its conformation and function. Clinically, mutations in SLC9A1 are associated with neurological disorders and certain cancers, highlighting its significance in both normal cellular function and disease states (Dong2021Structure; Fliegel2020Role; Orlowski2004Diversity).

## Structure
The SLC9A1 gene encodes the Na+/H+ exchanger 1 (NHE1), a membrane protein crucial for regulating intracellular pH and cell volume. The primary structure of NHE1 consists of 894 amino acids, with a calculated molecular weight of approximately 99,354 Da. It includes three putative N-linked glycosylation sites, which are common post-translational modifications (Sardet1989Molecular).

The secondary structure of NHE1 features multiple transmembrane alpha-helices. The protein is organized into a homodimer, with each monomer comprising a dimerization domain (transmembrane segments 1-3 and 7-10) and a core domain (transmembrane segments 4-6 and 11-13) (Dong2021Structure). The tertiary structure involves the arrangement of these helices, with specific transmembrane helices (TM5 and TM12) unwound in the middle, potentially forming an ion permeation pathway (Dong2021Structure).

In terms of quaternary structure, NHE1 forms a symmetrical homodimer, stabilized by hydrophobic helix-helix interactions, which is essential for its function in the plasma membrane (Poet2022How). The protein also includes a large intracellular tail with regulatory sites, contributing to its complex structure and function (Poet2022How). The NHE1-CHP1 complex undergoes conformational changes during the transport cycle, with an elevator-like mechanism facilitating ion exchange (Dong2021Structure).

## Function
The SLC9A1 gene encodes the Na+/H+ exchanger isoform 1 (NHE1), a crucial plasma membrane protein involved in maintaining intracellular pH by exchanging intracellular protons (H+) for extracellular sodium ions (Na+). This exchange is vital for protecting cells from acidification due to metabolic processes (Dong2021Structure; Fliegel2020Role). NHE1 is ubiquitously expressed in mammalian cells and plays a significant role in regulating cell volume, particularly in response to osmotic changes (Orlowski2004Diversity; Fliegel2020Role).

NHE1 is involved in various cellular processes, including cell growth, proliferation, differentiation, and apoptosis. It is essential for normal cell growth, as cells expressing inactive NHE1 mutants show reduced proliferation (Fliegel2020Role; Li2015A). The protein's activity is modulated by its interaction with calcineurin B-homologous protein 1 (CHP1), which is necessary for its biosynthetic maturation and pH sensitivity (Dong2021Structure).

In cardiac myocytes, NHE1 is localized in specific microdomains, such as intercalated disks and t-tubules, where it modulates pH-sensitive proteins, impacting impulse conduction and excitation-contraction coupling (Orlowski2004Diversity). The protein's function is also linked to cell morphology, adhesion, and migration through its association with cytoskeletal proteins (Orlowski2004Diversity).

## Clinical Significance
Mutations in the SLC9A1 gene, which encodes the Na+/H+ exchanger isoform 1 (NHE1), are linked to several neurological and developmental disorders. Notably, autosomal recessive mutations in SLC9A1 are associated with Lichtenstein-Knorr syndrome, characterized by cerebellar ataxia, sensorineural hearing loss, and developmental delays (Iwama2018A; Fliegel2020Role). Specific mutations, such as the Gly305Arg substitution, result in reduced protein expression and impaired targeting, leading to a loss of NHE1 activity (Fliegel2020Role). Another mutation, Asn266His, disrupts the transport mechanism without affecting protein targeting (Li2015A).

In gliomas, elevated SLC9A1 mRNA expression is associated with increased malignancy and poor prognosis. High expression levels are particularly noted in IDH-wildtype gliomas and the mesenchymal subtype, correlating with processes like angiogenesis and cell adhesion (Guan2018Elevated). Pharmacological inhibition of NHE1 has shown potential therapeutic benefits, reducing tumor volume and enhancing the efficacy of immunotherapies (Guan2018Elevated).

Mutations in SLC9A1 can also lead to cardiac conditions, such as myocardial hypertrophy and ischemic heart disease, due to dysregulated calcium influx and cell death under hypoxic conditions (Fliegel2020Role).

## Interactions
The SLC9A1 gene encodes the Na+/H+ exchanger 1 (NHE1), which interacts with various proteins that regulate its activity and localization. NHE1 binds to calmodulin (CaM) at two sites on its cytoplasmic C-terminal tail, which is crucial for its activation in response to extracellular signals (Bertrand1994The). Calcineurin homologous protein (CHP) binds to the juxtamembrane region of NHE1, stabilizing its active conformation (Lin1996A; Fliegel2020Role). Tescalcin, another calcium-binding protein, inhibits NHE1 by binding to the final 180 amino acids of its C-terminal tail (Slepkov2007Structural).

NHE1 also interacts with carbonic anhydrase II (CAII), which enhances its activity through phosphorylation-dependent mechanisms (Fliegel2020Role). The 14-3-3 protein binds to NHE1 when Ser703 is phosphorylated, stabilizing its active conformation (Slepkov2007Structural). Phosphatidylinositol 4,5-bisphosphate (PIP2) binds to motifs within the C-terminal domain, essential for optimal NHE1 activity (Pedersen2019The; Slepkov2007Structural). Heat-shock proteins HSP70 and HSP90 are involved in the folding and processing of NHE1 (Fliegel2020Role). NHE1 also interacts with ERM proteins (ezrin, radixin, moesin), linking it to the cytoskeleton and affecting cell shape and migration (Pedersen2019The; Slepkov2007Structural).


## References


[1. (Orlowski2004Diversity) John Orlowski and Sergio Grinstein. Diversity of the mammalian sodium/proton exchanger slc9 gene family. Pfl�gers Archiv European Journal of Physiology, 447(5):549–565, February 2004. URL: http://dx.doi.org/10.1007/s00424-003-1110-3, doi:10.1007/s00424-003-1110-3. This article has 521 citations.](https://doi.org/10.1007/s00424-003-1110-3)

[2. (Poet2022How) Mallorie Poet, Denis Doyen, Emmanuel Van Obberghen, Gisèle Jarretou, Yann Bouret, and Laurent Counillon. How does our knowledge on the na+/h+ exchanger nhe1 obtained by biochemical and molecular analyses keep up with its recent structure determination? Frontiers in Physiology, July 2022. URL: http://dx.doi.org/10.3389/fphys.2022.907587, doi:10.3389/fphys.2022.907587. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2022.907587)

[3. (Sardet1989Molecular) Claude Sardet, Arlette Franchi, and Jacques Pouysségur. Molecular cloning, primary structure, and expression of the human growth factor-activatable antiporter. Cell, 56(2):271–280, January 1989. URL: http://dx.doi.org/10.1016/0092-8674(89)90901-x, doi:10.1016/0092-8674(89)90901-x. This article has 573 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/0092-8674(89)90901-x)

[4. (Li2015A) Xiuju Li and Larry Fliegel. A novel human mutation in the slc9a1 gene results in abolition of na+/h+ exchanger activity. PLOS ONE, 10(3):e0119453, March 2015. URL: http://dx.doi.org/10.1371/journal.pone.0119453, doi:10.1371/journal.pone.0119453. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0119453)

[5. (Dong2021Structure) Yanli Dong, Yiwei Gao, Alina Ilie, DuSik Kim, Annie Boucher, Bin Li, Xuejun C. Zhang, John Orlowski, and Yan Zhao. Structure and mechanism of the human nhe1-chp1 complex. Nature Communications, June 2021. URL: http://dx.doi.org/10.1038/s41467-021-23496-z, doi:10.1038/s41467-021-23496-z. This article has 49 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-021-23496-z)

[6. (Iwama2018A) Kazuhiro Iwama, Hitoshi Osaka, Takahiro Ikeda, Satomi Mitsuhashi, Satoko Miyatake, Atsushi Takata, Noriko Miyake, Shuichi Ito, Takeshi Mizuguchi, and Naomichi Matsumoto. A novel slc9a1 mutation causes cerebellar ataxia. Journal of Human Genetics, 63(10):1049–1054, July 2018. URL: http://dx.doi.org/10.1038/s10038-018-0488-x, doi:10.1038/s10038-018-0488-x. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s10038-018-0488-x)

[7. (Lin1996A) X Lin and D L Barber. A calcineurin homologous protein inhibits gtpase-stimulated na-h exchange. Proceedings of the National Academy of Sciences, 93(22):12631–12636, October 1996. URL: http://dx.doi.org/10.1073/pnas.93.22.12631, doi:10.1073/pnas.93.22.12631. This article has 114 citations.](https://doi.org/10.1073/pnas.93.22.12631)

[8. (Fliegel2020Role) Larry Fliegel. Role of genetic mutations of the na+/h+ exchanger isoform 1, in human disease and protein targeting and activity. Molecular and Cellular Biochemistry, 476(2):1221–1232, November 2020. URL: http://dx.doi.org/10.1007/s11010-020-03984-4, doi:10.1007/s11010-020-03984-4. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-020-03984-4)

[9. (Guan2018Elevated) Xiudong Guan, Lanxin Luo, Gulnaz Begum, Gary Kohanbash, Qingkun Song, Aparna Rao, Nduka Amankulor, Baoshan Sun, Dandan Sun, and Wang Jia. Elevated na/h exchanger 1 (slc9a1) emerges as a marker for tumorigenesis and prognosis in gliomas. Journal of Experimental &amp; Clinical Cancer Research, October 2018. URL: http://dx.doi.org/10.1186/s13046-018-0923-z, doi:10.1186/s13046-018-0923-z. This article has 45 citations.](https://doi.org/10.1186/s13046-018-0923-z)

[10. (Pedersen2019The) S. F. Pedersen and L. Counillon. The slc9a-c mammalian na+/h+exchanger family: molecules, mechanisms, and physiology. Physiological Reviews, 99(4):2015–2113, October 2019. URL: http://dx.doi.org/10.1152/physrev.00028.2018, doi:10.1152/physrev.00028.2018. This article has 129 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00028.2018)

[11. (Slepkov2007Structural) Emily R. Slepkov, Jan K. Rainey, Brian D. Sykes, and Larry Fliegel. Structural and functional analysis of the na+/h+ exchanger. Biochemical Journal, 401(3):623–633, January 2007. URL: http://dx.doi.org/10.1042/bj20061062, doi:10.1042/bj20061062. This article has 196 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20061062)

[12. (Bertrand1994The) B. Bertrand, S. Wakabayashi, T. Ikeda, J. Pouysségur, and M. Shigekawa. The na+/h+ exchanger isoform 1 (nhe1) is a novel member of the calmodulin-binding proteins. identification and characterization of calmodulin-binding sites. Journal of Biological Chemistry, 269(18):13703–13709, May 1994. URL: http://dx.doi.org/10.1016/s0021-9258(17)36887-4, doi:10.1016/s0021-9258(17)36887-4. This article has 243 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(17)36887-4)